Regulatory Roles and Mechanisms of Oxylipins in Body Fat Deposition

YANG Xiaohua; ZHANG Fenglin; JIANG Qingyan; WANG Songbo

doi:10.3969/j.issn.1006-267x.2020.07.012

Chinese Journal of Animal Nutrition >

2020 , Vol. 32 >Issue 7: 3039 - 3048

DOI: https://doi.org/10.3969/j.issn.1006-267x.2020.07.012

Regulatory Roles and Mechanisms of Oxylipins in Body Fat Deposition

YANG Xiaohua ,
ZHANG Fenglin ,
JIANG Qingyan ,
WANG Songbo

Expand

Guangdong Provincial Key Laboratory of Animal Nutrition Control and UBT Lipid Suite Functional Fatty Acids Research Center, College of Animal Sciences, South China Agricultural University, Guangzhou 510642, China

Received date: 2019-12-11

Online published: 2020-07-15

Fold

Abstract

The fat deposition in different parts of the animals has important effects on the carcass quality and meat quality. Meanwhile, the excessive fat deposition in human body will result in obesity and the related metabolic diseases. Therefore, regulating fat deposition has great significance for improving animal product quality and human health. Oxylipins are a class of oxidative metabolites of polyunsaturated fatty acid (PUFA). More and more studies have shown that oxylipins have important regulatory effects on body fat deposition. This article summarizes the regulatory roles of oxylipins in the aspects of adipogenesis, fat metabolism browning of adipose tissue and thermogenesis, as well as the possible underlying mechanisms. This review provides reference for further understanding of the regulatory mechanisms and application of PUFA on body fat deposition.

Key words： oxylipins; fat deposition; adipogenesis; fat metabolism; browning

Cite this article

YANG Xiaohua , ZHANG Fenglin , JIANG Qingyan , WANG Songbo . Regulatory Roles and Mechanisms of Oxylipins in Body Fat Deposition[J]. Chinese Journal of Animal Nutrition, 2020 , 32(7) : 3039 -3048 . DOI: 10.3969/j.issn.1006-267x.2020.07.012

References

[1] ALGIRE C,MEDRIKOVA D,HERZIG S.White and brown adipose stem cells:from signaling to clinical implications[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2013,1831(5):896-904.

[2] DAVOLI R,BRAGLIA S.Molecular approaches in pig breeding to improve meat quality[J].Briefings in Functional Genomics & Proteomics,2007,6(4):313-321.
[3] PARLEE S D,LENTZ S I,MORI H,et al.Quantifying size and number of adipocytes in adipose tissue[J].Methods in Enzymology.2014,537:93-122.
[4] BUCKLEY J D,HOWE P R C.Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids[J].Obesity Reviews,2009,10(6):648-659.

[5] BELCHIOR T,PASCHOAL V A,MAGDALON J,et al.Omega-3 fatty acids protect from diet-induced obesity,glucose intolerance,and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions[J].Molecular Nutrition and Food Reserch,2015,59(5):957-967.

[6] TOURDOT B E,AHMED I,HOLINSTAT M.The emerging role of oxylipins in thrombosis and diabetes[J].Frontiers in Pharmacology,2014,4:176.
[7] BARQUISSAU V,GHANDOUR R A,AILHAUD G,et al.Control of adipogenesis by oxylipins,GPCRs and PPARs[J].Biochimie,2017,136:3-11.
[8] NAYEEM M A.Role of oxylipins in cardiovascular diseases[J].Acta Pharmacologica Sinica,2018,39(7):1142-1154.

[9] WANG W C,YANG J,YANG H X,et al.Effects of high-fat diet on plasma profiles of eicosanoid metabolites in mice[J].Prostaglandins & Other Lipid Mediators,2016,127:9-13.
[10] KEEVIL B G.LC-MS/MS analysis of steroids in the clinical laboratory[J].Clinical Biochemistry,2016,49(13/14):989-997.
[11] FUNK D C.Prostaglandins and leukotrienes:advances in eicosanoid biology[J].Science,2001,294(5548):1871-1875.

[12] IYER A,FAIRLIE D P,PRINS J B,et al.Inflammatory lipid mediators in adipocyte function and obesity[J].Nature Reviews Endocrinology,2010,6(2):71-82.

[13] KONKEL A,SCHUNCK W H.Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids[J].Biochimica et Biophysica Acta:Proteins and Proteomics,2011,1814(1):210-222.

[14] SHAHABI P,SIEST G,MEYER U A,et al.Human cytochrome P450 epoxygenases:variability in expression and role in inflammation-related disorders[J].Pharmacology & Therapeutics,2014,144(2):134-161.

[15] ASKARI A A,THOMSON S,EDIN M L,et al.Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells[J].Biochemical and Biophysical Research Communications,2014,446(2):633-637.

[16] YAMADA M,PROIA A D.8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea[J].Cornea,2000,19(3):S13-S20.
[17] GUIDO D M,MCKENNA R,MATHEWS W R.Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry[J].Analytical Biochemistry,1993,209(1):123-129.

[18] MANKU M S,OKA M,HORROBIN D F.Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid.Ⅰ.Effects of ethanol[J].Prostaglandins and Medicine,1979,3(2):119-128.

[19] IKEI K N,YEUNG J,APOPA P L,et al.Investigations of human platelet-type 12-lipoxygenase:role of lipoxygenase products in platelet activation[J].Journal of Lipid Research,2012,53(12):2546-2559.

[20] YAMANE M,ABE A,YAMANE S.High-performance liquid chromatography-thermospray mass spectrometry of epoxy polyunsaturated fatty acids and epoxyhydroxy polyunsaturated fatty acids from an incubation mixture of rat tissue homogenate[J].Journal of Chromatography B:Biomedical Sciences and Applications,1994,652(2):123-136.

[21] LARSSON N,LUNDSTRÖM S L,PINTO R,et al.Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans[J].European Respiratory Journal,2014,43(2):453-5463.

[22] BROWN R A.The Linoleic-to-linolenic dietary intake ratio:the fundamental implications of imbalance and excess looked at from both a functional and an evolutionary perspective:an overview[M]//HEGDE M,ZANWAR A,ADEKAR S.Omega-3 fatty acids.Berlin:Springer International Publishing,2016.
[23] BALAS L,GUICHARDANT M,DURAND T,et al.Confusion between protectin D1(PD1) and its isomer protectin DX (PDX).An overview on the dihydroxy-docosatrienes described to date[J].Biochimie,2014,99:1-7.
[24] VANROLLINS M,BAKER R C,SPRECHER H W,et al.Oxidation of docosahexaenoic acid by rat liver microsomes[J].Journal of Biological Chemistry,1984,259(9):5776-5783.
[25] DENG B,WANG C W,ARNARDOTTIR H H,et al.Maresin biosynthesis and identification of maresin 2,a new anti-inflammatory and pro-resolving mediator from human macrophages[J].PLoS One,2014,9(7):e102362.
[26] MORISSEAU C,INCEOGLU B,SCHMELZER K,et al.Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[J].Journal of Lipid Research,2010,51(12):3481-3490.

[27] SHINOHARA M,MIRAKAJ V,SERHAN C N.Functional metabolomics reveals novel active products in the DHA metabolome[J].Frontiers in Immunology,2012,3:81.
[28] BANNENBERG G,SERHAN C N.Specialized pro-resolving lipid mediators in the inflammatory response:an update[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2010,1801(12):1260-1273.

[29] WADA M,DELONG C J,HONG Y H,et al.Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products[J].Journal of Biological Chemistry,2007,282(31):22254-22266.

[30] ARNOLD C,KONKEL A,FISCHER R,et al.Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids[J].Pharmacological Reports,2010,62(3):536-547.

[31] MILLER C C,YAMAGUCHI R Y,ZIBOH V A.Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids[J].Lipids,1990,24(12):998-1003.
[32] TERANO T,SALMON J A,MONCADA S.Biosynthesis and biological activity of leukotriene B5[J].Prostaglandins,1984,27(2):217-232.

[33] GHABEN A L,SCHERER P E.Adipogenesis and metabolic health[J].Nature Reviews Molecular Cell Biology,2019,20(4):242-258.

[34] GESTA S,KAHN C R.White adipose tissue[M]//SYMONDS M E.Adipose tissue biology.Cham:Springer International Publishing,2017:149-99.
[35] WALDMAN M,BELLNER L,VANELLA L,et al.Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells,via PGC-1α activation,which is required for HO-1 expression and increased mitochondrial function[J].Stem Cells and Development,2016,25(14):1084-1094.

[36] LEIRIA L O,WANG C H,LYNES M D,et al.12-lipoxygenase regulates cold adaptation and glucose metabolism by producing the omega-3 lipid 12-HEPE from brown fat[J].Cell Metabolism,2019,30(4):768-783.

[37] ZAHRADKA P,NEUMANN S,AUKEMA H M,et al.Adipocyte lipid storage and adipokine production are modulated by lipoxygenase-derived oxylipins generated from 18-carbon fatty acids[J].International Journal of Biochemistry & Cell Biology,2017,88:23-30.
[38] LYNES M D,LEIRIA L O,LUNDH M,et al.The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue[J].Nature Medicine,2017,23(5):631-637.

[39] MASSIERA F,SAINT-MARC P,SEYDOUX J,et al.Arachidonic acid and prostacyclin signaling promote adipose tissue development:a human health concern?[J].Journal of Lipid Research,2003,44(2):271-279.

[40] GAILLARD D,NÉGREL R,LAGARDE M,et al.Requirement and role of arachidonic acid in the differentiation of pre-adipose cells[J].Biochemical Journal,1989,257(2):389-397.

[41] MILLER C W,CASIMIR D A,NTAMBI J M.The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha[J].Endocrinology,1996,137(12):5641-5650.

[42] TSUBOI H,SUGIMOTO Y,KAINOH T,et al.Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation[J].Biochemical and Biophysical Research Communications,2004,322(3):1066-1072.

[43] DEVCHAND P R,HIHI A K,PERROUD M,et al.Chemical probes that differentially modulate peroxisome proliferator-activated receptor α and BLTR,nuclear and cell surface receptors for leukotriene B₄[J].Journal of Biological Chemistry,1999,274(33):23341-23348.

[44] ZHA W B,EDIN M L,VENDROV K C,et al.Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity[J].Journal of Lipid Research,2014,55(10):2124-2136.

[45] TAKAHASHI H,HARA H,GOTO T,et al.13-oxo-9(Z),11(E),15(Z)-octadecatrienoic acid activates peroxisome proliferator-activated receptor γ in adipocytes[J].Lipids,2015,50(1):3-12.

[46] NAGY L,TONTONOZ P,ALVAREZ J G A,et al.Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ[J].Cell,1998,93(2):229-240.

[47] CHATZIPANTELI K,RUDOLPH S,AXELROD L.Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue[J].Diabetes,1992,41(8):927-935.

[48] HORRILLO R,GONZÁLEZ-PÉRIZ A,MARTÍNEZ-CLEMENTE M,et al.5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity[J].Journal of Immunology,2010,184(7):3978-3987.

[49] YAMADA H,KIKUCHI S,HAKOZAKI M,et al.8-hydroxyeicosapentaenoic acid decreases plasma and hepatic triglycerides via activation of peroxisome proliferator-activated receptor alpha in high-fat diet-induced obese mice[J].Journal of Lipid Research,2016,2016:7498508.
[50] JAWORSKI K,AHMADIAN M,DUNCAN R E,et al.AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency[J].Nature Medicine,2009,15(2):159-168.

[51] CHEN G Z,XU R F,ZHANG S S,et al.CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice[J].American Journal of Physiology:Endocrinology and Metabolism,2015,308(2):E97-E110.
[52] 张光磊,王勤华,欧阳富龙,等.褐色脂肪及其产热功能的研究进展[J].湖南饲料,2016(1):26-28.
[53] PISANI D F,GHANDOUR R A,BERANGER G E,et al.The ω6-fatty acid,arachidonic acid,regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway[J].Molecular Metabolism,2014,3(9):834-847.

[54] STEWART A,FISHER R A.Introduction:G protein-coupled receptors and RGS proteins[J].Progress in Molecular Biology and Translational Science,2015,133:1-11.
[55] AUBERT J,SAINT-MARC P,BELMONTE N,et al.Prostacyclin IP receptor up-regulates the early expression of C/EBPβ and C/EBPδ in preadipose cells[J].Molecular and Cellular Endocrinology,2000,160(1/2):149-156.
[56] VASSAUX G,GAILLARD D,AILHAUD G,et al.Prostacyclin is a specific effector of adipose cell differentiation.Its dual role as a cAMP-and Ca²⁺-elevating agent[J].Journal of Biological Chemistry,1992,267(16):11092-11097.
[57] WANG C J,LIU W L,YAO L,et al.Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease[J].British Journal of Pharmacology,2017,174(14):2358-2372.

[58] MARTÍNEZ-CLEMENTE M,CLÀRIA J,TITOS E.The 5-lipoxygenase/leukotriene pathway in obesity,insulin resistance,and fatty liver disease[J].Current Opinion in Clinical Nutrition and Metabolic Care,2011,14(4):347-353.

[59] MOTHE-SATNEY I,FILLOUX C,AMGHAR H,et al.Adipocytes secrete leukotrienes:contribution to obesity-associated inflammation and insulin resistance in mice[J].Diabetes,2012,61(9):2311-2319.

[60] GHOSHAL S,TRIVEDI D B,GRAF G A,et al.Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice[J].Journal of Biological Chemistry,2011,286(1):889-898.

[61] CALIGIURI S P,LOVE K,WINTER T,et al.Dietary linoleic acid and α-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats[J].The Journal of Nutrition,2013,143(9):1421-1431.

[62] MENDONÇA A M,CAYER L G J,PAULS S D,et al.Distinct effects of dietary ALA,EPA and DHA on rat adipose oxylipins vary by depot location and sex[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2018,129:13-24.
[63] CAYER L G J,MENDONÇA A M,PAULS S D,et al.Adipose tissue oxylipin profiles vary by anatomical site and are altered by dietary linoleic acid in rats[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2019,141:24-32.
[64] SCHUCHARDT J P,OSTERMANN A I,STORK L,et al.Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2017,121:76-87.
[65] BALVERS M G J,VERHOECKX K C M,BIJLSMA S,et al.Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues[J].Metabolomics,2012,8(6):1130-1147.

Options

Outlines

模态框（Modal）标题

Abstract

Cite this article

References